The expression of a melanoma-associated antigen (MAA), p97, on the cell surfaces of five human .melanoma cell lines was investigated with the recently developed mixed passive hemagglutination (MPHA) method. Two of these lines, HMV-I and HMV-II, were subclones separated by cloning from a common original cell line. In all cell lines except HMV-I, definite expression of p97 antigen was detected in MPHA. However, virtually no expression ofthe antigen was observed in the HMV-I cell line. These results were confirmed by immunoelectron microscopic study. The present study is meaningful for the following two reasons. First, it was shown that MPHA is a sensitive and conventional method for detection of tumor-associated surface antigens on cultured neoplastic cells. Second, this is the first report ofclonal variation in expression of p97 antigen between subclones of a human melanoma cell line. Clonal variation in expression of a MAA as shown in the present study may cause serious problems when a monoclonal antibody is used for immunodiagnosis or immunotherapy.